Sonali Fonseca - Aziyo Biologics Head Buses

Insider

Sonali Fonseca is Head Buses of Aziyo Biologics
Phone240 247 1170
Webhttps://www.aziyo.com

Aziyo Biologics Management Efficiency

The company has return on total asset (ROA) of (0.2875) % which means that it has lost $0.2875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.7514) %, meaning that it created substantial loss on money invested by shareholders. Aziyo Biologics' management efficiency ratios could be used to measure how well Aziyo Biologics manages its routine affairs as well as how well it operates its assets and liabilities.
Aziyo Biologics currently holds 34.89 M in liabilities with Debt to Equity (D/E) ratio of 3.5, implying the company greatly relies on financing operations through barrowing. Aziyo Biologics has a current ratio of 0.98, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Aziyo Biologics' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Salvador DadaEstablishment Labs Holdings
42
Matthew GetzArtivion
56
Thomas AckermanArtivion
66
Jesse SelnickSight Sciences
N/A
Leigh SalvoIRIDEX
N/A
S MansbachAvanos Medical
N/A
Stacie RodgersSight Sciences
N/A
Fuad AhmadIRIDEX
55
Mojirade JamesAvanos Medical
58
John LiuSight Sciences
N/A
Alan ConnaughtonLENSAR Inc
53
Bart BracyAnika Therapeutics
N/A
Keith SimeoneSTRATA Skin Sciences
N/A
Darrell RigelSTRATA Skin Sciences
73
Patrick MercerIRIDEX
52
David ColleranAnika Therapeutics
52
David CrawfordAvanos Medical
N/A
Joshua WellsArtivion
N/A
HuiLan WuAinos Inc
63
Jeffrey BettingerEstablishment Labs Holdings
N/A
John EsqAinos Inc
57
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic devicecardiovascular, orthopedicspinal repair, and soft tissue reconstruction markets. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland. Aziyo Biologics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 162 people. Aziyo Biologics (AZYO) is traded on NASDAQ Exchange in USA and employs 151 people.

Management Performance

Aziyo Biologics Leadership Team

Elected by the shareholders, the Aziyo Biologics' board of directors comprises two types of representatives: Aziyo Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aziyo. The board's role is to monitor Aziyo Biologics' management team and ensure that shareholders' interests are well served. Aziyo Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aziyo Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Erica Elchin, VP Operations
Matthew Ferguson, Chief Officer
Randal Mills, Pres CoFounder
MS MBA, Ex Chairman
Michelle Williams, Chief Officer
Jeffry Hamet, Treasurer Fin
Sonali Fonseca, Head Buses
Courtney Guyer, VP Marketing
Thomas Englese, Chief Officer

Aziyo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aziyo Biologics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Aziyo Biologics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aziyo Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aziyo Biologics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to NRG Energy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NRG Energy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NRG Energy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NRG Energy to buy it.
The correlation of NRG Energy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NRG Energy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NRG Energy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NRG Energy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Consideration for investing in Aziyo Stock

If you are still planning to invest in Aziyo Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo Biologics' history and understand the potential risks before investing.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas